Soleno Therapeutics Inc. buy Guggenheim
Start price
28.03.25
/
50%
€65.90
Target price
28.03.26
-
Performance (%)
-60.88%
End price
30.03.26
€25.78
Summary
This prediction ended on 30.03.26 with a price of €25.78. The BUY prediction by Guggenheim for Soleno Therapeutics Inc. performed very badly with a performance of -60.88%. Guggenheim has a follow-up prediction for Soleno Therapeutics Inc. where he still thinks Soleno Therapeutics Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Soleno Therapeutics Inc. | -0.135% | -0.135% | -29.660% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % |
Comments by Guggenheim for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for SLNO provided by MarketBeat
In the thread Trading Soleno Therapeutics Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€67.90
08.05.25
08.05.25
€85.63
08.05.26
08.05.26
-33.81%
23.04.26
23.04.26
Stopped prediction by Guggenheim for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.30
27.08.25
27.08.25
€91.11
27.08.26
27.08.26
-24.22%
23.04.26
23.04.26
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€69.15
07.08.25
07.08.25
€90.90
07.08.26
07.08.26
-35.01%
23.04.26
23.04.26
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.30
21.11.23
21.11.23
€36.55
21.11.24
21.11.24
106.38%
22.11.24
22.11.24